Biotechnology
- 990.755
- -10.875-1.09%
Alterity Therapeutics Ltd Files For Mixed Shelf Of Up To $50M
Alterity Therapeutics Ltd Files For Mixed Shelf Of Up To $50M
Immuron Ltd Owned Ateria Health Launches Juvia in Australia
Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the tr
Comparing Baudax Bio (NASDAQ:BXRX) & Curative Biotechnology (OTCMKTS:CUBT)
Curative Biotechnology (OTCMKTS:CUBT – Get Rating) and Baudax Bio (NASDAQ:BXRX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two business
Shenzhen Bioeasy Biotechnology Unit Gets Registration Certificates for Medical Devices
01:45 AM EDT, 10/24/2022 (MT Newswires) -- Shenzhen Xiupu Biotechnology, a unit of Shenzhen Bioeasy Biotechnology (SHE:300942), received registration certificates from the Guangdong Provincial Drug Ad
Assenagon Asset Management S.A. Acquires 162,531 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI)
Assenagon Asset Management S.A. boosted its holdings in shares of Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Rating) by 651.2% in the 2nd quarter, according to its most recent Form 13F filing with
Commonwealth Equity Services LLC Sells 173 Shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)
Commonwealth Equity Services LLC trimmed its position in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE – Get Rating) by 1.8% during the 2nd quarter, according to its most re
CX Institutional Makes New Investment in Vir Biotechnology, Inc. (NASDAQ:VIR)
CX Institutional purchased a new position in shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) during the second quarter, Holdings Channel.com reports. The firm purchased 29,812 shares of
Global Biotechnology Kits Market Report 2022: Increasing Investments in Biotechnological Sector Creating Growth - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Biotechnology Kits Market by Kit Type, Technology, Parameter Tested, Microorganism, Purpose, End-user, Region: Competition Forecast and Opportunities to 2027" repo
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, Nov. 3, 2022, following the
AbbVie To Buy UK-based Biotechnology Company DJS Antibodies For About $255 Mln
SpikImm, a Biotechnology Company Founded by Truffle Capital Under License From the Institut Pasteur, Announces That the Clinical Trials for SPK001, Its Monoclonal Antibody Against SARS-COV-2, Have Begun
This Clinical Trial Has Been Awarded National Priority Research Status by the French Government PARIS--(BUSINESS WIRE)--SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a Fre
Note: The capital market is full of optimism! This Australian company is about to take off
4 ‘quality’ ASX shares to buy in scary times: expert
4 ‘quality’ ASX shares to buy in scary times: expert
BHP, CSL & FMG: How these 3 ASX blue-chip stocks are doing this month
Own CSL shares? Boss reveals why biotech is ‘not fussed’ about exiting COVID vaccine race
Australia's CSL in exclusive talks for $7 bln buyout of Swiss Vifor Pharma - report
CSL Committed to mRNA Program
Australia’s CSL makes $11.7bn bid for Swiss pharma Vifor
UniQure, CSL Behring Say Late-Stage Trial of Hemophilia Treatment Meets Primary Endpoint
07:53 AM EST, 12/09/2021 (MT Newswires) -- UniQure N.V. (QURE) and CSL Behring said Thursday that a phase 3 trial of gene therapy etranacogene dezaparvovec met its primary endpoint in treating patie